PND29 Scenario Analyses on Major Impactful and Uncertain Inputs of the Cost-Effectiveness Model of Fremanezumab From a Healthcare System Perspective in England
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.813
https://www.valueinhealthjournal.com/article/S1098-3015(21)01030-5/fulltext
Section Title :
Section Order :
10318
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01030-5&doi=10.1016/j.jval.2021.04.813